Compare Gap Inc (GAP) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gap Inc vs GeneDx Holdings Corp — how do they compare? Gap Inc trades at $23.23 (market cap $8.21B), while GeneDx Holdings Corp trades at $67.29 (market cap $2.02B). The key difference: Gap Inc is far larger — about 4.1× GeneDx Holdings Corp's market cap, and Gap Inc pays a 3% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gap Inc for 37 Days and GeneDx Holdings Corp for 19 Days on average.
| GAP | WGS | |
|---|---|---|
Market Cap | $8.21B | $2.02B |
Volume | 5,192,917 | 734,640 |
Sector | Consumer Cyclical | Health |
52-Week High | $29.13 | $167.51 |
52-Week Low | $18.35 | $34.51 |
Typical Hold Time | 37 Days | 19 Days |
Enterprise Value | $11.44B | $2.05B |
Dividend Yield | 3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gap Inc. (GAP) trades at $23.15, down 1.95% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $25.67. The company shows strong profitability with a net income margin of 8.14% and ROE of 33.78%, supported by recent earnings beats in Q1 and Q2 2026. Recent developments include a 'fashiontainment' partnership with boy band JYT and a new board appointment, signaling strategic brand revitalization efforts.
The outlook for Gap is cautiously optimistic, with valuation metrics like a P/E of 7.04 and P/S of 0.58 suggesting potential upside. Key risks include uneven brand performance, with Old Navy sales declining, and macroeconomic pressures on consumer spending. Earnings growth and successful brand initiatives are critical catalysts for further stock appreciation.
GeneDx (WGS) trades at $68.09, down 0.64% today, with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue beating expectations but negative profitability metrics, including a -23.4% net income margin. Recent news highlights product launches and industry recognition, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth opportunity in genomic testing with strong analyst support, but faces significant execution risks from persistent losses and high valuation multiples. Key catalysts include continued revenue growth and path to profitability, while risks include competitive pressures and cash flow challenges from negative operating cash flow in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Gap Inc
Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates nearly 3,000 stores in North America, Europe, and Asia and franchises about 600 stores in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.
Read more on GAP →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
